✦ LIBER ✦

Is anti-cholinesterase therapy of Alzheimer’s disease delaying progression?

✍ Scribed by Giacobini, E.

Book ID: 125337883
Publisher: Springer-Verlag
Year: 2001
Tongue: English
Weight: 116 KB
Volume: 13
Category: Article
ISSN: 1720-8319
DOI: 10.1007/BF03351483

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effectiveness of antidementia drugs in d

Effectiveness of antidementia drugs in delaying Alzheimer's disease progression

✍ Rountree, Susan D.; Atri, Alireza; Lopez, Oscar L.; Doody, Rachelle S. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 550 KB

Is Long-Term Treatment of Alzheimer’s Di

Is Long-Term Treatment of Alzheimer’s Disease with Cholinesterase Inhibitor Therapy Justified?

✍ Dr Ben Seltzer 📂 Article 📅 2007 🏛 Springer International Publishing AG 🌐 English ⚖ 179 KB

Anti-inflammatory therapy in Alzheimer’s

Anti-inflammatory therapy in Alzheimer’s disease: is hope still alive?

✍ W. A. van Gool; P. S. Aisen; P. Eikelenboom 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 310 KB

Impact of current therapy on Alzheimer's

Impact of current therapy on Alzheimer's disease progression

✍ Ezio Giacobini 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 193 KB

Progress in pharmacotherapy of Alzheimer

Progress in pharmacotherapy of Alzheimer's disease: Symptomatic stabilization with cholinesterase inhibitors

✍ E. Giacobini 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 324 KB

Switching cholinesterase inhibitor thera

Switching cholinesterase inhibitor therapy in Alzheimer's disease—donepezil to rivastigmine, is it worth it?

✍ Roger Bullock; Claire Connolly 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 34 KB 👁 1 views

Switching from donepezil to rivastigmine was bene®cial in cognitive and global terms in 55.0% of the patients with Alzheimer's disease studied. \* Side-effects on donepezil and rivastigmine were independent of one another. \* It may be possible to extend the positive effects that cholinesterase inhi